Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia (2013)

  • Authors:
  • USP affiliated authors: CUNHA, THIAGO MATTAR - FMRP ; FERREIRA, SERGIO HENRIQUE - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP
  • USP Schools: FMRP; FMRP; FMRP
  • DOI: 10.1007/s00210-012-0813-4
  • Subjects: DOR; ARTICULAÇÕES; NEUTRÓFILOS (METABOLISMO); DOENÇAS IMUNOLÓGICAS; MODELOS ANIMAIS DE DOENÇAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00210-012-0813-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Naunyn-Schmiedeberg's Archives of Pharmacology

    ISSN: 0028-1298

    Citescore - 2017: 2.29

    SJR - 2017: 0.836

    SNIP - 2017: 0.784


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2482854pcd 2482854 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GUERRERO, Ana T.; ZAPERLON, Ana C; VIEIRA, Silvio M; et al. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn-Schmiedeberg's Archives of Pharmacology, Heidelberg, v. 386, n. 1, p. 51-59, 2013. Disponível em: < http://dx.doi.org/10.1007/s00210-012-0813-4 > DOI: 10.1007/s00210-012-0813-4.
    • APA

      Guerrero, A. T., Zaperlon, A. C., Vieira, S. M., Pinto, L. G., Ferreira, S. H., Cunha, F. de Q., et al. (2013). The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn-Schmiedeberg's Archives of Pharmacology, 386( 1), 51-59. doi:10.1007/s00210-012-0813-4
    • NLM

      Guerrero AT, Zaperlon AC, Vieira SM, Pinto LG, Ferreira SH, Cunha F de Q, Verri Junior WA, Cunha TM. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 1): 51-59.Available from: http://dx.doi.org/10.1007/s00210-012-0813-4
    • Vancouver

      Guerrero AT, Zaperlon AC, Vieira SM, Pinto LG, Ferreira SH, Cunha F de Q, Verri Junior WA, Cunha TM. The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 1): 51-59.Available from: http://dx.doi.org/10.1007/s00210-012-0813-4

    Referências citadas na obra
    Benveniste J, Roubin R, Chignard M, Jouvin-march E, LeCouedic J (1982) Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. Agents Actions 12:711–713
    Bisgaard H, Kristensen JK (1985) Leukotriene B4 produces hyperalgesia in humans. Prostaglandins 30:791–797
    Bonnet J, Loiseau AM, Orvoen M, Bessin P (1981) Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. Agents Actions 11:559–562
    Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209
    Braquet P, Rola-Pleszczynski M (1987) Platelet-activating factor and cellular immune responses. Immunol Today 8:345–352
    Cunha TM, Verri WA Jr, Vivancos GG, Moreira IF, Reis S, Parada CA, Cunha FQ, Ferreira SH (2004) An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37:401–407
    Cunha TM, Verri WA Jr, Schivo IR, Napimoga MH, Parada CA, Poole S, Teixeira MM, Ferreira SH, Cunha FQ (2008) Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 83:824–832
    Czarnetzki BM, Benveniste J (1981a) Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes: I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids 29:317–326
    Czarnetzki BM, Benveniste J (1981b) Effect of synthetic PAF-acether on human neutrophil function. Agents Actions 11:549–550
    Gaudreault E, Stankova J, Rola-Pleszczynski M (2005) Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis. Prostaglandins Other Lipid Mediat 75:25–34
    Gegout P, Gillet P, Chevrier D, Guingamp C, Terlain B, Netter P (1994) Characterization of zymosan-induced arthritis in the rat: effects on joint inflammation and cartilage metabolism. Life Sci 55:321–326
    Guerrero AT, Verri WA Jr, Cunha TM, Silva TA, Rocha FA, Ferreira SH, Cunha FQ, Parada CA (2006) Hypernociception elicited by tibio-tarsal joint flexion in mice: a novel experimental arthritis model for pharmacological screening. Pharmacol Biochem Behav 84:244–251
    Guerrero AT, Verri WA Jr, Cunha TM, Silva TA, Schivo IR, Dal-Secco D, Canetti C, Rocha FA, Parada CA, Cunha FQ, Ferreira SH (2008) Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2. J Leukoc Biol 83:122–130
    Hasegawa S, Kohro Y, Shiratori M, Ishii S, Shimizu T, Tsuda M, Inoue K (2010) Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One 5:e10467
    Hilliquin P, Guinot P, Chermat-Izard V, Puechal X, Menkes CJ (1995a) Production of PAF –acether by synovial fluid neutrophils in rheumatoid arthritis. Inflamm Res 44:313–316
    Hilliquin P, Guinot P, Chermat-Izard V, Puechal X, Menkes CJ (1995b) Treatment of rheumatoid arthritis with platelet activating factor antagonist BN 50730. J Rheumatol 22:1651–1654
    Hopkins NK, Schaub RG, Gorman RR (1984) Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer. Biochim Biophys Acta 805:30–36
    Howat D, Desa F, Chander C, Moore A, Willoughby DA (1990) The synergism between platelet-activating factor and interleukin-1 on cartilage breakdown. J Lipid Med 2:5143–5149
    Hwang SB, Lam MH, Pong SS (1986) Ionic and GTP regulation of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. J Biol Chem 261:532–537
    Ishii S, Nagase T, Shimizu T (2002) Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 68–69:599–609
    Keystone EC, Schorlemmer HU, Pope C, Allison AC (1977) Zymosan-induced arthritis: a model of chonic proliferative arthritis following activation of the alternative pathway of complement. Arthritis Rheum 20:1396–1401
    Kuitert LM, Angus RM, Barnes NC, Barnes PJ, Bone MF, Chung KF, Fairfax AJ, Higenbotham TW, O'Connor BJ, Piotrowska B et al (1995) Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. Am J Respir Crit Care Med 151:1331–1335
    Levine JD, Lau W, Kwiat G, Goetzl EJ (1984) Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 225:743–745
    Ley K, Linnemann G, Meinen M, Stoolman LM, Gaehtgens P (1993) Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery. Blood 81:177–185
    Lynch JM, Lofner GZ, Betz SJ, Henson PM (1979) The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immun 123:1219–1226
    Miguélez R, Palácios I, Navarro FA, Gutierrez S, Sanchez-Pernaute O, Egido J, Gonzalez E, Herrero-Beaumont G (1996) Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. J Lipid Mediat Cell Signal 13:35–49
    Millan MJ (1999) The induction of pain: an integrative review. Prog Neurobiol 57:1–164
    Morita K, Morioka N, Abdin J, Kitayama S, Nakata Y, Dohi T (2004) Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain 111:351–359
    Okubo M, Yamanaka H, Kobayashi K, Kanda H, Dai Y, Noguchi K (2012) Up-regulation of platelet-activating factor synthases and its receptor in spinal cord contribute to development of neuropathic pain following peripheral nerve injury. Mol Pain. doi: 10.1186/1744-8069-8-8
    Palacios I, Miguélez R, Sánchez-Pernaute O, Gutierrez S, Egido J, Herrero-Beaumont G (1999) A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice. J Rheumatol 26:1080–1086
    Pettipher ER, Higgs GA, Henderson B (1987) PAF-acether in chronic arthritis. Agents Actions 21:98–103
    Roubin R, Mencia-Huerta JM, Benveniste J (1982) Release of platelet-activating factor (PAF-acether) and leukotrienes C and D from inflammatory macrophages. Eur J Immunol 12:141–146
    Shio MT, Ribeiro-Dias F, Timenetsky J, Jancar S (2004) PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells. Exp Cell Res 298:296–304
    Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40:643–672
    Ting E, Guerrero AT, Cunha TM, Verri WA Jr, Taylor SM, Woodruff TM, Cunha FQ, Ferreira SH (2008) Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain. Br J Pharmacol 153:1043–1053
    Tsuda M, Ishii S, Masuda T, Hasegawa S, Nakamura K, Nagata K, Yamashita T, Furue H, Tozaki-Saitoh H, Yoshimura M, Koizumi S, Shimizu T, Inoue K (2007) Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor. J Neurochem 102:1658–1668
    Vargaftig BB, Ferreira SH (1981) Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors. Braz J Med Biol Res 14:187–189
    Verri WA Jr, Cunha TM, Magro DA, Guerrero AT, Vieira SM, Carregaro V, Souza GR, Henriques MG, Ferreira SH, Cunha FQ (2009) Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn-Schmiedebergs Arch Pharmacol 379:271–279
    Wang HY, Yue TL, Firestein G, Friedman E (1994) Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein. J Neurochem 63:1720–1725
    Zarco P, Maestre C, Herrero-Beaumont G, González E, Garcia-Hoyo R, Navarro FJ, Braquet P, Egido J (1992) Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits. Clin Exp Immunol 88:318–323
    Zhang Q, Sitzman LA, Al-Hassani M, Cai S, Pollok KE, Travers JB, Hingtgen CM (2009) Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia. J Invest Dermatol 129:167–174